UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026393
Receipt number R000030116
Scientific Title Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.
Date of disclosure of the study information 2017/03/04
Last modified on 2022/04/05 12:25:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.

Acronym

Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.

Scientific Title

Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.

Scientific Title:Acronym

Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.

Region

Japan


Condition

Condition

polycystic ovarian syndrome

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify if myoinositol supplementation improves in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Oocyte pickup count, mature oocyte count/rate, fertilization rate, blastocyst rate, and live birth rate

Key secondary outcomes

Clinical pregnancy rate, implantation rate, and miscarriage rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Oral administration of 4g/day myoinositol plus 400microgram/day folate supplement for 15 days (subject group) 400microgram/day folate supplement for 15 days (control group)

Interventions/Control_2

Oral administration of 400microgram/day folate supplement for 15 days (control group)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

39 years-old >=

Gender

Female

Key inclusion criteria

Infertile patients with polycystic ovarian syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection

Key exclusion criteria

Participants with a history of hyper-sensitivity to rice products

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kotaro
Middle name
Last name Kitaya

Organization

Reproduction Clinic Osaka

Division name

IVF Center

Zip code

5300011

Address

Grand Front Tower-A 15F, 4-20 Oofuka-cho, Kita-ku, Osaka, 530-0011, Japan

TEL

0661363344

Email

kitaya@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Kotaro
Middle name
Last name Kitaya

Organization

Reproduction Clinic Osaka

Division name

IVF Center

Zip code

5300011

Address

Tower-A 15F, 4-20 Oofuka-cho, Kita-ku, Osaka, 530-0011, Japan

TEL

0661363344

Homepage URL


Email

kitaya@koto.kpu-m.ac.jp


Sponsor or person

Institute

Reproduction Clinic Osaka

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Reproduction Clinic Osaka

Address

Tower-A 15F, 4-20 Oofuka-cho, Kita-ku, Osaka, 530-0011, Japan

Tel

0661363344

Email

kitaya@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 04 Day


Related information

URL releasing protocol

https://doi.org/10.12891/ceog4567.2019

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.12891/ceog4567.2019

Number of participants that the trial has enrolled

50

Results

Myoinositol supplementation on intracytoplasmic sperm injection outcome in Japanese infertile polycystic ovarian syndrome women with non-obese less-androgenic phenotype: a prospective controlled observational study

K. Kitaya, Y. Takaya, R. Nishiyama, K. Yamaguchi, H. Matsubayashi, T. Takeuchi, S. Mizuta1, T. Ishikawa

Clin. Exp. Obstet. Gynecol. 2019, 46(4), 549-552

Results date posted

2022 Year 04 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2019 Year 08 Month 11 Day

Baseline Characteristics

Infertile polycystic ovarian syndrome women with non-obese less-androgenic phenotype

Participant flow

Non-randomized prospective controlled observational study

Adverse events

None.

Outcome measures

Oocyte retrieval outcome/
Assisted Reproductive Technology Outcome

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 02 Month 20 Day

Date of IRB

2017 Year 02 Month 28 Day

Anticipated trial start date

2017 Year 03 Month 04 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 03 Month 04 Day

Last modified on

2022 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030116


Research Plan
Registered date File name
2020/04/07 Text, PCOS Myoinositol.docx

Research case data specifications
Registered date File name
2020/04/07 Text, PCOS Myoinositol.docx

Research case data
Registered date File name
2020/04/07 Table, PCOS Myoinositol.docx